Colestid Granule, For Suspension
NDC Package 0009-0260-17
Package Information
Colestid (colestipol hydrochloride) granules is colestipol is used along with a proper diet to lower cholesterol in the blood. This formulation utilizes a granule, for suspension delivery system. Marketed by Pharmacia & Upjohn Company Llc, this product is identified by NDC 0009-0260 and is authorized under FDA application NDA017563.
Identification & Billing
- RxCUI: 1048450 - colestipol HCl 5 GM Granules For Oral Suspension
- RxCUI: 1048450 - colestipol hydrochloride 5000 MG Granules for Oral Suspension
- RxCUI: 1048450 - colestipol hydrochloride 5 GM Granules For Oral Suspension
- RxCUI: 1048452 - Colestid 5 GM Granules For Oral Suspension
- RxCUI: 1048452 - colestipol hydrochloride 5000 MG Granules for Oral Suspension [Colestid]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0009 - Pharmacia & Upjohn Company Llc
- 0009-0260 - Colestid
- 0009-0260-17 - 1 BOTTLE in 1 CARTON / 300 g in 1 BOTTLE
- 0009-0260 - Colestid
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0009-0260). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0009-0260-17 identifies a specific commercial package of 1 bottle in 1 carton / 300 g in 1 bottle of Colestid, a human prescription drug labeled by Pharmacia & Upjohn Company Llc. This granule, for suspension is formulated for oral use and contains colestipol hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pharmacia & Upjohn Company Llc on June 01, 1977. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Colestipol is used along with a proper diet to lower cholesterol in the blood. Lowering cholesterol helps decrease the risk for strokes and heart attacks. In addition to a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. This medication is known as a bile acid-binding resin. It works by removing bile acid from the body. In people with high cholesterol, this causes the liver to make more bile acid by using cholesterol in the blood. This helps to lower the cholesterol levels.
How is this Pharmacia & Upjohn Company Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00009026017. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 300 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.